“…The lack of widespread adoption of tramadol as an alternative local anaesthetic agent in clinical practice is likely due to the excellent safety, efficacy and established history of use of traditional amide-based local anaesthetics. Tramadol has however been associated with requiring less post-operative analgesia requirement ( Altunkaya et al, 2004 , Cekic et al, 2013 , Demiraran et al, 2013 , Heiba et al, 2012 ; ( Jabalameli et al, 2012 ) Kakagia et al, 2012 , Kargi et al, 2008 , Kargi et al, 2010 , Mitra et al, 2017 , Ozyilmaz et al, 2012 , Robaux et al, 2004 , Ugur et al, 2013 , Vahabi et al, 2011 ), lower post-operative pain scores ( Cekic et al, 2013 , Demiraran et al, 2013 , Heiba et al, 2012 ; ( Jabalameli et al, 2012 ) Kakagia et al, 2012 , Sahmeddini et al, 2017 , Ugur et al, 2013 ), prolonged analgesic and anaesthetic effects ( Behdad et al, 2013 , Cekic et al, 2013 , Kapral et al, 1999 , Robaux et al, 2004 ), and delaying the time to the first analgesia post-surgery ( Altunkaya et al, 2004 , Mitra et al, 2017 , Ozyilmaz et al, 2012 ) when compared to conventional local anaesthetics. To date, no study has primarily reviewed the prevalence of local and systemic adverse effects of tramadol when used as a local anaesthetic in the oral environment.…”